Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
Disease Markers|December 30, 1998
Monoclonal antibody recognizing a core epitope on mucinP L Devine, R J Quin, P W Shield, et al.The International Journal of Biological Markers|October 1, 1995
Prostate-specific antigen (PSA) and cancer-associated serum antigen (CASA) in distinguishing benign and malignant prostate diseaseP L Devine, M D Walsh, M A McGuckin, et al.The American Journal of Tropical Medicine and Hygiene|February 1, 1995
Tropical spastic paraparesis on the Caribbean coast of ColombiaF Dangond, J S Daza, A Rosania, et al.Breast Cancer Research and Treatment|June 1, 1995
CA15-3, CASA, MSA, and TPS as diagnostic serum markers in breast cancerP L Devine, M A Duroux, R J Quin, et al.Disease Markers|July 31, 1999
Serum mucin antigen (CASA) as a marker of amiodarone-induced pulmonary toxicityP L Devine, W J Siebert, S L Morton, et al.Journal of Leukocyte Biology|October 16, 2002
MUC1 epithelial mucin (CD227) is expressed by activated dendritic cellsM Wykes, K P A MacDonald, M Tran, et al.The British Journal of Ophthalmology|November 6, 2015
Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trialHemal Mehta, Samantha Fraser-Bell, Aaron Yeung, et al.Ophthalmology|August 27, 2014
A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX studyMark C Gillies, Lyndell L Lim, Anna Campain, et al.Journal of Medicinal Chemistry|August 6, 1993
Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-1-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1' -biphenyl]-4-yl]-methyl]-4-[2-(trifluoroacetyl)-1H-pyrrol-1-yl]-1H- imidazole-5-carboxylic acid (CI-996)I Sircar, J C Hodges, J Quin, et al.Journal of Medicinal Chemistry|September 15, 1995
Derivatives of 5-[[1-(4'-carboxybenzyl)imidazolyl]methylidene]hydantoins as orally active angiotensin II receptor antagonistsJ J Edmunds, S Klutchko, J M Hamby, et al.Pageof 7